Signaling and Functional Properties of lnterleukin-16

References

• Center D. M., Cruikshank W. W. Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. J. Immunol. 1982; 128: 2563–2568
   PubMed Web of Science ®Google Scholar
• Cruikshank W. W., Center D. M. Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF). J. Immunol. 1982; 128: 2569–2574
   PubMed Web of Science ®Google Scholar
• Center D M, Kornfeld H., Cruikshank W. W. Interleukin 16 and its function as a CD4 ligand. Immunol. Today 1996; 17: 476–481
   PubMedGoogle Scholar
• Cruikshank W. W., Center D. M., Nisar N., Natke B., Theodore A., Kornfeld H. Molecular and functional analysis of a lymphocyte chemoattractant factor: Association of biologic function with CD4 expression. Proc. Natl. Acad. Sci. USA 1994; 91: 5109–5113
   PubMed Web of Science ®Google Scholar
• Woods D., Bryant P. Z0–1, DIgA and PSD-95/SAP90: homologous proteins in tight, septate and synaptic cell junctions. Mechanisms of Development 1995; 44: 85–89
   Google Scholar
• Laberge S., Cruikshank W. W., Kornfeld H., Center D. M. Histamine-induced secretion of lymphocyte chemoattractant factor from CD8+ T cells is independent of transcription and translation: Evidence for constitutive protein synthesis and storage. J. Immunol. 1995; 155: 2902–2910
   PubMed Web of Science ®Google Scholar
• Laberge S., Cruikshank W. W., Kornfeld H., Beer D. J., Center D. M. Secretion of IL-16 (lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T cells in vitro. J. Immunol. 1996; 56: 310–315
   Google Scholar
• Baier M., Werner A., Bannert N., Metzner K., Kurth R. HIV suppression by interleukin-16. Nature 1995; 378: 563
   PubMed Web of Science ®Google Scholar
• Hessel E. M., Cruikshank W. W., VanOosterhout A. J.M., Center D. M., VanLoveren H., Nijkamp F. P. Detection of lymphocyte chemoattractant factor (LCF) in a murine model for allergic asthma. Am. Rev. Resp. Dis 1995; 151: A776
   Google Scholar
• Keane J., Cruikshank W. W., Kornfeld H., Center D. M. Crossspecies reactivity and recognition of the CD4 dependent interleukin lymphocyte chemoattractant factor (LCF). Am. J. Resp. Crit. Care Med 1995; 149: 264a
   Google Scholar
• VanEpps D. E., Potter J. W., Durant D. A. Migration of human helper/inducer T cells in response to supernatants from Con A-stimulated suppressor/cytotoxic T cells. J. Immunol. 1983; 130: 2727–2733
   PubMedGoogle Scholar
• Berman J. S., Beer D. J., Cruikshank W. W., Center D. M. Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset. Cell. Immunol. 1985; 95: 105–112
   PubMed Web of Science ®Google Scholar
• Center D. M., Cruikshank W. W., Berman J. S., Beer D. J. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand. J. Immunol. 1983; 131: 1856–1859
   Google Scholar
• Berman J., McFadden R., Cruikshank W., Center D. M., Beer D. J. Functional characteristics of histamine receptor-bearing human mononuclear cells: II. Identification and characterization of two histamine-induced human lymphokines that alter lymphocyte migration. J. Immunol. 1984; 133: 1495–1504
   PubMedGoogle Scholar
• Vannier E., Dinarello C. A. Histamine enhances interleukin (IL)-1-induced gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells: Comparison with IL-1 receptor antagonist. J. Clin. Invest. 1993; 92: 281–289
   PubMedGoogle Scholar
• Lim K., Wan H.-C, Bozza P., Resnick M., Wong D. T., Cruikshank W. W., Kornfeld H., Center D. M., Weller P. F. Human eosinophils elaborate the lymphocyte chemoattractants: IL-16 (lymphocyte chemoattractant factor) and RANTES. J. Immunol. 1996; 156: 2566–2570
   PubMed Web of Science ®Google Scholar
• Bellini A., Yoshimura H., Vitori E., Marini M., Mattoli S. J., Bronchial epithelial cells of patients with asthma release chemoattractant factors for T lymphocytes. J. Allergy Clin. Immunol. 1993; 92: 412–24
   PubMed Web of Science ®Google Scholar
• Arima M., Plitt J. R., Stellato C., Schwiebert L. M., Schleimer R. P. The expression of lymphocyte chemoattractant factor (LCF) in human bronchial epithelial cells. J. Allergy and Clin. Immunol 1995; 97: 293A
   Google Scholar
• Theodore A. C., Center D. M., Kornfeld H., Cruikshank W. W. Suppression of the immune response by the CD4 ligand Interleukin 16. J. Immunol. 1996; 157: 1958–1964
   PubMed Web of Science ®Google Scholar
• Cruikshank W. W., Berman J. S., Theodore A. C., Bernardo J., Center D. M. Lymphokine activation of T4+ T lymphocytes and monocytes. J. Immunol. 1987; 138: 3817–3825
   PubMed Web of Science ®Google Scholar
• Sakihama T., Smolyar A., Reinherz E. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120. Proc. Natl. Acad. Sci. USA 1995; 92: 6444–6448
   PubMedGoogle Scholar
• Konig R., Shen X., Germain R. N. Involvement of both major histocompatibility complex class IIα and β chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J. Exp. Med. 1995; 182: 779–787
   PubMedGoogle Scholar
• Sakihama T., Smolyar A., Reinherz E. Molecular recognition of antigen involves lattice formation between CD4, MHC class II and TCR molecules. Immunol. Today 1995; 16: 581–587
   PubMedGoogle Scholar
• Rand T., Cruikshank W. W., Center D. M., Weller P. F. CD4-mediated stimulation of human eosinophils: Lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J. Exp. Med. 1991; 173: 1521–1528
   PubMed Web of Science ®Google Scholar
• Dragic T., Litwin V., Allaway G., Martin S. R., Huang Y., Nagashima K. A., Cayanan C., Maddon P. J., Koup R. A., Moore J. P., Paxton W. A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381: 667–673
   PubMed Web of Science ®Google Scholar
• Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., DiMarzio P., Marmon S., Sutton R. E., Hill C. M., Davis C. B., Peiper S. C., Schall T. J., Littman D. R., Landau N. R. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996; 381: 661–666
   PubMed Web of Science ®Google Scholar
• Cruikshank W. W., Greenstein J. L., Theodore A. C., Center D. M. Lymphocyte chemoattractant factor induces CD4-dependent intracytoplasmic signaling in lymphocytes. J. Immunol. 1991; 146: 2928–2934
   PubMed Web of Science ®Google Scholar
• Ryan T., Cruikshank W. W., Kornfeld H., Collins T., Center D. M. The CD4-associated tyrosine kinase p561ck is required for lymphocyte chemoattractant factor-induced T lymphocyte migration. J. Biol. Chem. 1995; 270: 17081–17086
   PubMed Web of Science ®Google Scholar
• Parada N. A., Cruikshank W. W., Kornfeld H., Center D. M. IL-16- and other CD4 ligand-induced migration is dependent upon protein kinase C. Cell. Immunol. 1996; 168: 100–106
   PubMed Web of Science ®Google Scholar
• Kornfeld H., Bernan J. S., Beer D. J., Center D. M. Induction of human T lymphocyte motility by interleukin 2. J. Immunol. 1985; 134: 3887–3890
   PubMed Web of Science ®Google Scholar
• Cruikshank W. W., Center D. M. Priming of IL-2R-, CD4+ human blood T cells in vitro with the lymphocyte chemoattractant factor (LCF) for proliferation in response to IL-2. Clinical Research 1994; 42: 281 A
   Google Scholar
• Cruikshank W. W., Fine G., Taylor K., Center D. M. Autocrine and paracrine growth regulation of CD4+ cell lines by IL-16. The FASEB J 1996; 10: A1485
   PubMedGoogle Scholar
• Wan H.-C, Lazarovits A. I., Cruikshank W. W., Kornfeld H., Center D. M., Weller P. F. Expression of α4/β7 integrin on eosinphils and modulation of α4-integrin-mediated eosinophil adhesion via CD4. Int. Arch. Allergy Immunol. 1995; 107: 343–344
   PubMedGoogle Scholar
• Chirmule N., Goonewardena H., Pahwa S., Pasieka R., Kalyanaraman V. S., Pahwa S. HIV-1 envelope glycoprotein induces activation of activated protein-1 in CD4+ T cells. J. Biol. Chem. 1995; 270: 19364–19369
   PubMedGoogle Scholar
• Juszczak R. J., Howard T., Truneh A., Culp J., Kassis S. Effect of human immunodeficiency virus gp120 glycoprotein in the association of the protein tyrosine kinase p561ck with CD4 in human T lymphocytes. J. Biol. Chem. 1991; 266: 11176–11183
   PubMedGoogle Scholar
• Cruikshank W. W., Center D. M., Pyle S. W., Kornfeld H. Biologic activities of HIV-1 envelope glycoprotein: the effects of crosslinking. Biomed Pharmacother. 1990; 44: 5–12
   PubMedGoogle Scholar
• Merrill J. E., Koyanagi Y., Chen I. S.Y. Interleukin-1 and tumor necrosis factor α can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J. Virol. 1989; 63: 4404–4408
   PubMedGoogle Scholar
• Clouse K. A., Cosentino L. M., Weih K. A., Pyle S. W., Robbins P. B., Hochstein H. D., Natarajan V., Farrar W. L. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J. Immunol. 1991; 147: 2892–2901
   PubMed Web of Science ®Google Scholar
• Wahl L., Corcoran M. L., Pyle S. W. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin-1. Proc. Natl. Acad. Sci. USA 1989; 86: 621–625
   PubMed Web of Science ®Google Scholar
• Kornfeld H., Cruikshank W. W., Pyle S. W., Berman J. S., Center D. M. Lymphocyte activation by HIV-1 envelope glycoprotein. Nature 1988; 335: 445–448
   PubMed Web of Science ®Google Scholar
• Chirmule N., Kalyanaraman V. S., Oyaizu N., Slade H. B., Pahwa S. Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein gp120 of human immunodeficiency virus. Blood 1990; 75: 152–162
   PubMedGoogle Scholar
• Cefai D., Ferrer M., Serpente N., Idziorek T., Dautry-Varsat A., Debre P., Bismuth G. Internalization of HIV glycoprotein gp120 is associated with down modulation of membrane CD4 and p561ck together with impairment of T cell activation. J. Immunol. 1992; 149: 285–291
   PubMedGoogle Scholar
• Chace J. H., Cowdery J. S., Field E. H. Effect of anti-CD4 on CD4 subsets. J. Immunol. 1994; 152: 405–412
   PubMedGoogle Scholar
• Bank I., Chess L. Perturbation of the T4 molecule transmits a negative signal to T cells. J. Exp. Med. 1985; 162: 1294–1299
   PubMed Web of Science ®Google Scholar
• Cruikshank W. W., Lim K., Theodore A. C., Cook J., Fine G., Weller P. F., Center D. M. IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation. J. Immunol. 1996; 157: 5240–5248
   PubMed Web of Science ®Google Scholar
• Boehme S. A., Zheng L., Lenardo M. J. Analysis of the CD4 coreceptor and activation-induced costimulatory molecules in antigen-mediated mature T lymphocyte death. J. Immunol. 1995; 155: 1703–1712
   PubMed Web of Science ®Google Scholar
• Mackewicz C. E., Levy J. A., Cruikshank W. W., Kornfeld H., Center D. M. Role of IL-16 in HIV replication. Nature 1996; 383: 488–489
   PubMedGoogle Scholar
• Maciaszek J. W., Parada N. A., Cruikshank W. W., Center D. M., Kornfeld H., Viglianti G. A. Interleukin-16 represses HIV-1 promoter activity. J. Immunol. 1997; 158: 5–8
   PubMed Web of Science ®Google Scholar
• Cruikshank W. W., Teran L., Tarpy R., Holgate S., Center D. M. Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1α (MIP1α) in bronchoalveolar lavage fluid of antigen-challenged asthmatics. Am. J. Resp. Cell and Mol. Biol. 1995; 13: 738–747
   PubMed Web of Science ®Google Scholar
• Laberge S., Ernst P., Ghaffar O., Cruikshank W. W., Kornfeld H., Center D. M., Hamid Q. Increased expression of interleukin-16 in bronchial mucosa of subjects with atopic asthma. Am. J. Resp. Cell and Mol. Biol. 1997; 17: 193–202
   PubMed Web of Science ®Google Scholar
• Falus A., Meretey K. Histamine: an early messenger in inflammatory and immune reactions. Immunol. Today 1992; 13: 154–156
   PubMedGoogle Scholar